Answers are grounded in this paper and cite their sources.
Potentiating effects of beta-eudesmol on neuromuscular blockade were investigated in phrenic nerve-diaphragm muscles of normal and alloxan-diabetic mice. Pretreatment with beta-eudesmol potentiated the blocking effects of succinylcholine to a greater extent in diabetic muscles than in normal ones. This effect was saturated after 30-min pretreatment in normal muscles. Further potentiation was observed after 60-min pretreatment in diabetic muscles. These results suggest that beta-eudesmol modifies the sensitivity of diabetic mice to depolarizing blockers so that they have a higher susceptibility to these compounds.
No takes yet. Share an insight, caveat, or question.
Muroi et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: